{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

TechMediaBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Launches Mudra Pro for Early Pre-Orders

June 4, 2026Wearable Devices (NASDAQ: WLDS) announced the launch of Mudra Pro for early pre-orders, offering OEMs, enterprise innovation teams, researchers and developers access to product specifications, software development kit capabilities and pilot program resources. Developed through the company’s ai6 Labs initiative, the AI-powered neural wristband features a thinner ergonomic design and adds a photoplethysmography sensor alongside electromyography and inertial measurement unit sensors, expanding sensing capabilities for cardiovascular monitoring, gesture recognition and intent-based interfaces while helping customers accelerate development and commercialization efforts.


Fed Beige Book Highlights Resilient Manufacturing, Consumer Spending Divide and Persistent Cost Pressures

June 4, 2026CNW CurrenSees Exploring the policies, markets and global events influencing currencies and the movement of money worldwide Federal Reserve districts reported slight to moderate economic growth, led by continued strength in manufacturing activity. Consumer spending remained mixed, with higher-income households showing resilience while middle- and lower-income consumers faced increasing financial strain.


Forward Industries Inc. (NASDAQ: FWDI) to Join Russell 2000(R) and 3000(R) Indexes as Part of Russell Indexes Semi-Annual Reconstitution

June 4, 2026 Forward Industries, a Solana (SOL) treasury company that buys, holds, and strategically deploys SOL, has announced that it will soon join the Russell 2000(R) and 3000(R) indexes. Forward will join the indexes as a part of Russell indexes semi-annual reconstitution in June, which captures the 3,000 largest US stocks as of April 30, 2026, and ranks them by market capitalization.


BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Drug-Delivery Market Growth

June 4, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining growing investor interest in platform biotech companies as the global drug-delivery market advances toward an estimated $410 billion opportunity. The editorial highlights increasing industry focus on overcoming challenges related to drug penetration, tumor targeting, therapeutic resistance and maintaining consistent intratumoral exposure, while spotlighting Oncotelic’s Sapu003 and Deciparticle platform as examples of nanotechnology-driven drug-delivery approaches designed to enhance the clinical utility of existing therapies through improved pharmacokinetics and delivery performance.


FBI Seizes Crypto Worth $8 Billion in Intercontinental Swoop

June 4, 2026The FBI has announced the seizure of roughly $8 billion in crypto and the arrest of hundreds linked to large-scale online fraud networks operating across several continents. Officials say the effort focused on dismantling “scam compounds” linked to organized crime groups, including the Democratic Karen Benevolent Army (DKBA).


Trump Signs Executive Order Establishing Oversight of Frontier AI Technologies

June 4, 2026On Tuesday, President Trump signed an executive order that establishes federal government oversight over some AI models. The order seeks to give the Commerce, Defense, Homeland Security and Treasury departments the leeway to conduct cyber capability assessments of advanced AI models before they are made available to the public.


Former CIA Operative Goes on Trial on Gold Theft Charges

June 4, 2026A former high-level Central Intelligence Agency (CIA) operative accused of stealing hundreds of gold bars valued at over $40 million is set to appear in court this week after a Virginia judge postponed his initial hearing. David Rush, who previously held an executive-level position in the agency, remains in custody following his arrest.


Spanish Researchers Develop New Material That Could Transform EVs

June 4, 2026Spanish researchers have developed a new material that has sharply improved carbon nanotube conductivity, potentially opening a path to replace copper wire in EVs, drones, and aircraft. Published in Science, the research comes from the Institute of Nanoscience and Materials of Aragon and the IMDEA Materials Institute.


Ukraine Uses AI Drones in Its Attacks on Russian Supply Lines

June 4, 2026Ukraine is intensifying efforts to disrupt Russian military supply networks in occupied territories, aided by a new generation of AI-powered drones that are extending the reach and precision of its attacks, according to military analysts. Away from Ukraine’s use of AI in warfare, the technology is also being leveraged by companies like Core AI Holdings Inc.


MiningNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in Editorial on AI-Driven Energy Demand

June 4, 2026This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced its inclusion in an AINewsWire editorial examining how the rapid growth of artificial intelligence is reshaping global electricity demand and increasing pressure on existing power infrastructure.


TechMediaBreaks – BOXABL Featured in TechMediaWire Editorial on Housing Innovation and Scalable Construction Technologies

June 4, 2026BOXABL was featured in a TechMediaWire editorial examining how factory-built housing, automation and advanced manufacturing technologies are emerging as potential solutions to the nation’s housing affordability and supply challenges. The article highlights BOXABL’s foldable, factory-built housing platform, its proposed business combination with FG Merger II Corp.


TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Pipeline Expansion and Clinical Milestones in Mid-Year Shareholder Update

June 4, 2026Kairos Pharma (NYSE American: KAPA) provided a mid-year 2026 update highlighting plans to expand its oncology pipeline through the proposed acquisition of worldwide rights to CL-741, a Phase 1-ready oral c-MET kinase inhibitor from Celyn Therapeutics targeting EGFR-mutated lung cancer and other cancers. The company said CL-741 would complement its existing portfolio, which includes ENV-105, KROS-201, KROS-102 and ENV-205.